|
2020-01-10 |
2019-12-30 |
S
Sale
|
Riva Ridge Capital Management LP
|
50,000
-5.1%
2.50
USD 125,000
|
50,000
-5.1%
|
2.50
|
USD 125,000
|
|
|
2020-01-10 |
2019-12-23 |
S
Sale
|
Riva Ridge Capital Management LP
|
250,000
-20.2%
2.50
USD 625,000
|
250,000
-20.2%
|
2.50
|
USD 625,000
|
|
|
2018-01-03 |
2018-01-02 |
PS
Planned sale
|
Shea Patrick M
Chief Commercial Officer
Officer
|
910
-2.4%
1.00
USD 910
|
910
-2.4%
|
1.00
|
USD 910
|
|
|
2017-10-03 |
2017-10-02 |
PS
Planned sale
|
Strobeck Mark
Chief Operating Officer
|
8,700
-41.9%
1.29
USD 11,223
|
8,700
-41.9%
|
1.29
|
USD 11,223
|
|
|
2017-10-03 |
2017-10-02 |
PS
Planned sale
|
Shea Patrick M
Chief Commercial Officer
|
910
-2.3%
1.30
USD 1,183
|
910
-2.3%
|
1.30
|
USD 1,183
|
|
|
2017-07-06 |
2017-07-03 |
PS
Planned sale
|
Musial Stan
Chief Financial Officer
Officer
|
3,480
-7.6%
2.36
USD 8,213
|
3,480
-7.6%
|
2.36
|
USD 8,213
|
|
|
2017-07-06 |
2017-07-03 |
PS
Planned sale
|
Shea Patrick M
Chief Commercial Officer
Officer
|
910
-2.3%
2.35
USD 2,139
|
910
-2.3%
|
2.35
|
USD 2,139
|
|
|
2017-07-06 |
2017-07-03 |
PS
Planned sale
|
VARKI PAUL
SVP, GC & Chief Compliance Off
Officer
|
806
-2.7%
2.35
USD 1,894
|
806
-2.7%
|
2.35
|
USD 1,894
|
|
|
2017-07-05 |
2017-06-30 |
PS
Planned sale
|
Strobeck Mark
Chief Operating Officer
Officer
|
8,700
-29.5%
2.39
USD 20,793
|
8,700
-29.5%
|
2.39
|
USD 20,793
|
|
|
2017-04-05 |
2017-04-03 |
PS
Planned sale
|
Musial Stan
Chief Financial Officer
|
8,613
-15.8%
5.04
USD 43,410
|
8,613
-15.8%
|
5.04
|
USD 43,410
|
|
|
2017-04-04 |
2017-04-03 |
PS
Planned sale
|
VARKI PAUL
SVP, GC & Chief Compliance Off
|
806
-2.7%
5.05
USD 4,070
|
806
-2.7%
|
5.05
|
USD 4,070
|
|
|
2017-04-04 |
2017-03-31 |
PS
Planned sale
|
Dayno Jeffrey M.
Chief Medical Officer
|
536
-2.9%
5.16
USD 2,766
|
536
-2.9%
|
5.16
|
USD 2,766
|
|
|
2017-03-31 |
2017-03-31 |
PS
Planned sale
|
Strobeck Mark
Chief Operating Officer
|
8,700
-22.8%
5.11
USD 44,457
|
8,700
-22.8%
|
5.11
|
USD 44,457
|
|
|
2017-03-21 |
2017-03-20 |
PS
Planned sale
|
Shea Patrick M
Chief Commercial Officer
|
4,250
-10.0%
4.75
USD 20,188
|
4,250
-10.0%
|
4.75
|
USD 20,188
|
|
|
2017-01-04 |
2017-01-03 |
PS
Planned sale
|
VARKI PAUL
SVP, GC & Chief Compliance Off
|
806
-2.6%
7.75
USD 6,247
|
806
-2.6%
|
7.75
|
USD 6,247
|
|
|
2017-01-04 |
2017-01-03 |
PS
Planned sale
|
Dayno Jeffrey M.
Chief Medical Officer
|
536
-2.8%
7.75
USD 4,154
|
536
-2.8%
|
7.75
|
USD 4,154
|
|
|
2017-01-04 |
2017-01-03 |
PS
Planned sale
|
Musial Stan
Chief Financial Officer
|
13,480
-19.8%
7.73
USD 104,200
|
13,480
-19.8%
|
7.73
|
USD 104,200
|
|
|
2017-01-04 |
2016-12-30 |
PS
Planned sale
|
Strobeck Mark
Chief Operating Officer
|
8,700
-18.6%
7.81
USD 67,947
|
8,700
-18.6%
|
7.81
|
USD 67,947
|
|
|
2016-10-04 |
2016-10-03 |
PS
Planned sale
|
VARKI PAUL
SVP, GC & Chief Compliance Off
Officer
|
806
-2.6%
7.56
USD 6,093
|
806
-2.6%
|
7.56
|
USD 6,093
|
|
|
2016-10-04 |
2016-10-03 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
15,000
-6.0%
7.47
USD 112,050
|
15,000
-6.0%
|
7.47
|
USD 112,050
|
|
|
2016-10-04 |
2016-10-03 |
PS
Planned sale
|
Musial Stan
Chief Financial Officer
Officer
|
13,480
-16.5%
7.47
USD 100,696
|
13,480
-16.5%
|
7.47
|
USD 100,696
|
|
|
2016-10-03 |
2016-09-30 |
PS
Planned sale
|
Strobeck Mark
Chief Operating Officer
Officer
|
25,000
-34.8%
7.59
USD 189,750
|
25,000
-34.8%
|
7.59
|
USD 189,750
|
|
|
2016-10-03 |
2016-09-30 |
PS
Planned sale
|
Dayno Jeffrey M.
Chief Medical Officer
Officer
|
536
-2.7%
7.69
USD 4,122
|
536
-2.7%
|
7.69
|
USD 4,122
|
|
|
2016-10-03 |
2016-09-30 |
PS
Planned sale
|
Strobeck Mark
Chief Operating Officer
Officer
|
8,700
-10.8%
7.55
USD 65,685
|
8,700
-10.8%
|
7.55
|
USD 65,685
|
|
|
2016-07-06 |
2016-07-06 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
5,000
-2.0%
5.02
USD 25,100
|
5,000
-2.0%
|
5.02
|
USD 25,100
|
|
|
2016-07-06 |
2016-07-05 |
PS
Planned sale
|
Musial Stan
Chief Financial Officer
Officer
|
3,480
-4.1%
5.05
USD 17,574
|
3,480
-4.1%
|
5.05
|
USD 17,574
|
|
|
2016-07-06 |
2016-07-05 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
5,000
-1.9%
4.94
USD 24,700
|
5,000
-1.9%
|
4.94
|
USD 24,700
|
|
|
2016-07-06 |
2016-07-01 |
PS
Planned sale
|
Musial Stan
Chief Financial Officer
Officer
|
10,000
-10.5%
5.06
USD 50,600
|
10,000
-10.5%
|
5.06
|
USD 50,600
|
|
|
2016-07-06 |
2016-07-01 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
5,000
-1.9%
5.07
USD 25,350
|
5,000
-1.9%
|
5.07
|
USD 25,350
|
|
|
2016-07-05 |
2016-06-30 |
PS
Planned sale
|
Strobeck Mark
Chief Business Officer
Officer
|
8,700
-9.7%
4.68
USD 40,716
|
8,700
-9.7%
|
4.68
|
USD 40,716
|
|
|
2016-07-05 |
2016-06-30 |
PS
Planned sale
|
Dayno Jeffrey M.
Chief Medical Officer
Officer
|
536
-2.6%
4.65
USD 2,492
|
536
-2.6%
|
4.65
|
USD 2,492
|
|
|
2016-04-06 |
2016-04-05 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
5,000
-1.9%
6.99
USD 34,950
|
5,000
-1.9%
|
6.99
|
USD 34,950
|
|
|
2016-04-06 |
2016-04-05 |
PS
Planned sale
|
Melloy Deanne F.
Chief Commercial Officer
Officer
|
860
-2.5%
6.96
USD 5,986
|
860
-2.5%
|
6.96
|
USD 5,986
|
|
|
2016-04-05 |
2016-04-04 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
5,000
-1.8%
6.99
USD 34,950
|
5,000
-1.8%
|
6.99
|
USD 34,950
|
|
|
2016-04-05 |
2016-04-01 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
5,000
-1.8%
6.94
USD 34,700
|
5,000
-1.8%
|
6.94
|
USD 34,700
|
|
|
2016-04-04 |
2016-04-01 |
PS
Planned sale
|
Musial Stan
Chief Financial Officer
Officer
|
3,480
-3.5%
7.02
USD 24,430
|
3,480
-3.5%
|
7.02
|
USD 24,430
|
|
|
2016-04-04 |
2016-03-31 |
PS
Planned sale
|
Dayno Jeffrey M.
Chief Medical Officer
Officer
|
536
-2.6%
6.72
USD 3,602
|
536
-2.6%
|
6.72
|
USD 3,602
|
|
|
2016-04-04 |
2016-03-31 |
PS
Planned sale
|
Strobeck Mark
Chief Business Officer
Officer
|
8,700
-8.9%
6.70
USD 58,290
|
8,700
-8.9%
|
6.70
|
USD 58,290
|
|
|
2016-01-12 |
2016-01-11 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
3,000
-1.1%
9.65
USD 28,950
|
3,000
-1.1%
|
9.65
|
USD 28,950
|
|
|
2016-01-12 |
2016-01-08 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
4,000
-1.4%
9.69
USD 38,760
|
4,000
-1.4%
|
9.69
|
USD 38,760
|
|
|
2016-01-12 |
2016-01-07 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
3,000
-1.0%
9.61
USD 28,830
|
3,000
-1.0%
|
9.61
|
USD 28,830
|
|
|
2016-01-07 |
2016-01-06 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
2,100
-0.7%
10.16
USD 21,336
|
2,100
-0.7%
|
10.16
|
USD 21,336
|
|
|
2016-01-07 |
2016-01-05 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
1,400
-0.5%
11.11
USD 15,554
|
1,400
-0.5%
|
11.11
|
USD 15,554
|
|
|
2016-01-07 |
2016-01-04 |
PS
Planned sale
|
Radie Robert S
President and CEO
Executive Director
|
1,500
-0.5%
10.47
USD 15,705
|
1,500
-0.5%
|
10.47
|
USD 15,705
|
|
|
2016-01-05 |
2016-01-04 |
PS
Planned sale
|
Melloy Deanne F.
Chief Commercial Officer
Officer
|
860
-2.4%
10.45
USD 8,987
|
860
-2.4%
|
10.45
|
USD 8,987
|
|
|
2016-01-05 |
2016-01-04 |
PS
Planned sale
|
Musial Stan
Chief Financial Officer
Officer
|
3,480
-3.4%
10.68
USD 37,166
|
3,480
-3.4%
|
10.68
|
USD 37,166
|
|
|
2016-01-05 |
2015-12-31 |
PS
Planned sale
|
Dayno Jeffrey M.
Chief Medical Officer
Officer
|
536
-2.5%
10.40
USD 5,574
|
536
-2.5%
|
10.40
|
USD 5,574
|
|
|
2016-01-05 |
2015-12-31 |
PS
Planned sale
|
Strobeck Mark
Chief Business Officer
Officer
|
8,700
-8.2%
10.40
USD 90,480
|
8,700
-8.2%
|
10.40
|
USD 90,480
|
|
|
2014-02-13 |
2014-02-11 |
B
Purchase
|
Index Venture Associates III Ltd
Large shareholder
|
266,771
+36.0%
12.00
USD 3,201,252
|
266,771
+36.0%
|
12.00
|
USD 3,201,252
|
|
|
2014-02-13 |
2014-02-11 |
B
Purchase
|
Index Venture Associates III Ltd
Large shareholder
|
4,862
+23.1%
12.00
USD 58,344
|
4,862
+23.1%
|
12.00
|
USD 58,344
|
|
|
2014-02-13 |
2014-02-11 |
B
Purchase
|
Index Venture Associates III Ltd
Large shareholder
|
1,170
+8.2%
12.00
USD 14,040
|
1,170
+8.2%
|
12.00
|
USD 14,040
|
|
|
2014-02-13 |
2014-02-11 |
B
Purchase
|
Index Venture Associates III Ltd
Large shareholder
|
65,692
+8.2%
12.00
USD 788,304
|
65,692
+8.2%
|
12.00
|
USD 788,304
|
|
|
2014-02-13 |
2014-02-11 |
B
Purchase
|
Danish Biotech SPV I P/S
Large shareholder
|
83,333
+36.0%
12.00
USD 999,996
|
83,333
+36.0%
|
12.00
|
USD 999,996
|
|
|
2014-02-13 |
2014-02-11 |
B
Purchase
|
Danish Biotech SPV I P/S
Large shareholder
|
156,250
+8.4%
12.00
USD 1,875,000
|
156,250
+8.4%
|
12.00
|
USD 1,875,000
|
|
|
2014-02-13 |
2014-02-11 |
B
Purchase
|
Index Venture Associates III Ltd
Large shareholder
|
32,338
+8.2%
12.00
USD 388,056
|
32,338
+8.2%
|
12.00
|
USD 388,056
|
|
|
2014-02-12 |
2014-02-11 |
B
Purchase
|
SEGERROS ANDREAS Rutger
Non-Executive Director
Large shareholder
|
133,333
+7.7%
12.00
USD 1,599,996
|
133,333
+7.7%
|
12.00
|
USD 1,599,996
|
|
|
2014-02-12 |
2014-02-11 |
B
Purchase
|
FORMELA JEAN FRANCOIS
Non-Executive Director
Large shareholder
|
41,667
+2.0%
12.00
USD 500,004
|
41,667
+2.0%
|
12.00
|
USD 500,004
|
|
|
2014-02-12 |
2014-02-11 |
B
Purchase
|
Atlas Venture Fund VII L P
Large shareholder
|
41,667
+2.0%
12.00
USD 500,004
|
41,667
+2.0%
|
12.00
|
USD 500,004
|
|
|
2014-02-12 |
2014-02-11 |
B
Purchase
|
AGUIAR-LUCANDER RENEE
Non-Executive Director
|
83,333
+36.0%
12.00
USD 999,996
|
83,333
+36.0%
|
12.00
|
USD 999,996
|
|
|
2014-02-12 |
2014-02-11 |
B
Purchase
|
SUNSTONE LIFE SCIENCE VENTURES FUND II K/S
Large shareholder
|
133,333
+7.7%
12.00
USD 1,599,996
|
133,333
+7.7%
|
12.00
|
USD 1,599,996
|
|
